Open AccessImpact of MGMT Promoter Methylation as a Prognostic Marker in Patients with High Grade Glioma: A Single-Center Observational Study
Author(s) -
Vinu Sarathy,
Srinivasa Belagutty Jayappa,
Bhanu Prakash Lalkota,
Kiran Pura Krishnamurthy,
Vishal Kulkarni,
Samuel Luke Koramati,
Mohammad Nasiruddin,
Radheshyam Naik
Publication year - 2019
Publication title -
journal of cancer therapy
Language(s) - English
Resource type - Journals
eISSN - 2151-1942
pISSN - 2151-1934
DOI - 10.4236/jct.2019.1010068
Subject(s) - methylation , glioma , methyltransferase , temozolomide , irinotecan , bevacizumab , oncology , dna methylation , cancer research , medicine , promoter , adjuvant , biology , gene , cancer , chemotherapy , genetics , gene expression , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom